Nissink, J. Willem M.
AstraZeneca,
United Kingdom
2025 Rank: 300826
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1469 out of 112089 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 300826 | 342610 |
| Total Cites | 312 | 323 |
| H-index | 10 | 10 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 27 | 28 |
| Number of Single+First+Last Authored Papers | 14 | 14 |
| Total Cites to Single+First+Last Authored Papers | 94 | 96 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 278 | 285 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.13 |
| Self-Citation Percentage |
3.41%
|
|
Nissink, J. Willem M.
AstraZeneca,
United Kingdom
2024 Rank: 363575
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 1904 out of 105998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 363575 | 409781 |
| Total Cites | 295 | 302 |
| H-index | 8 | 8 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 17 | 17 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 95 | 95 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 272 | 277 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.09 |
| Self-Citation Percentage |
2.32%
|
|
Nissink, J. Willem M.
AstraZeneca,
United Kingdom
2023 Rank: 343911
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 1800 out of 99369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 343911 | 381779 |
| Total Cites | 325 | 335 |
| H-index | 8 | 8 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 17 | 18 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 110 | 113 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 295 | 302 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.11 |
| Self-Citation Percentage |
2.99%
|
|
Nissink, J. Willem M.
AstraZeneca,
United Kingdom
2022 Rank: 215360
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 926 out of 94672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 215360 | 222216 |
| Total Cites | 322 | 348 |
| H-index | 9 | 10 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 27 | 32 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 109 | 115 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 300 | 317 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.10 |
| Self-Citation Percentage |
7.47%
|
|
Nissink, J. Willem M.
AstraZeneca,
United Kingdom
2021 Rank: 185961
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 735 out of 88725 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 185961 | 205788 |
| Total Cites | 511 | 532 |
| H-index | 12 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 47 | 49 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 168 | 172 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 474 | 489 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.09 |
| Self-Citation Percentage |
3.95%
|
|
Nissink, J. Willem M.
AstraZeneca,
United Kingdom
2020 Rank: 227692
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 1016 out of 80622 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 227692 | 257044 |
| Total Cites | 289 | 301 |
| H-index | 9 | 9 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 35 | 37 |
| Number of Single+First+Last Authored Papers | 18 | 18 |
| Total Cites to Single+First+Last Authored Papers | 100 | 105 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 267 | 275 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.09 |
| Self-Citation Percentage |
3.99%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.